Skip to content
Acamprosate
Campral (acamprosate) is a small molecule pharmaceutical. Acamprosate was first approved as Campral on 2004-07-29. It is used to treat alcoholism in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
chemically-induced disordersD064419
mental disordersD001523
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acamprosate calcium
Tradename
Company
Number
Date
Products
CAMPRALForest LaboratoriesN-021431 DISCN2004-07-29
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
acamprosate calciumANDA2022-11-17
campralNew Drug Application2016-08-06
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
alcoholismEFO_0003829D000437F10.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N07: Other nervous system drugs in atc
N07B: Drugs used in addictive disorders
N07BB: Drugs used in alcohol dependence
N07BB03: Acamprosate
HCPCS
No data
Clinical
Clinical Trials
777 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Overactive urinary bladderD053201EFO_1000781N32.8151017151458
StrokeD020521EFO_0000712I63.9491513543
Cerebral palsyD002547G80271341135
Muscle spasticityD009128HP_0001257151181035
TorticollisD014103HP_0000473F45.848107532
Migraine disordersD008881EFO_0003821G432597627
Urinary incontinenceD014549HP_0000020R3214105524
Urge urinary incontinenceD053202EFO_0006865N39.413254214
HyperhidrosisD006945HP_00009753224314
BlepharospasmD001764G24.51354213
Show 69 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Tennis elbowD013716EFO_1001896M77.1437
Myofascial pain syndromesD009209EFO_100105412216
SialorrheaD012798HP_0002307K11.75316
Plantar fasciitisD036981EFO_1001909M72.23225
Temporomandibular joint disordersD013705M26.612215
VulvodyniaD056650N94.81134
HeadacheD006261HP_0002315R51224
Dystonic disordersD020821G241123
Erectile dysfunctionD007172EFO_0004234F52.21323
Cluster headacheD003027HP_0012199G44.002213
Show 25 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lower urinary tract symptomsD059411EFO_00080081113
SmilingD012904112
Abdominal herniaD046449K46112
Major depressive disorderD003865EFO_0003761F22112
TendinopathyD052256EFO_1001434M77.922
Diabetes mellitusD003920EFO_0000400E08-E13112
Back painD001416HP_0003418M54112
OsteoarthritisD010003EFO_0002506M15-M19122
Neck painD019547HP_0030833M54.21112
ContractureD003286EFO_0003899M62.4112
Show 43 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PsoriasisD011565EFO_0000676L4022
Hemorrhagic strokeD00008330211
Internal carotid artery dissectionD02021511
Vertebral artery dissectionD020217I77.7411
Myelodysplastic syndromesD009190D4611
Myeloid leukemia acuteD015470C92.011
Gingival overgrowthD019214K06.111
Treatment-resistant depressive disorderD06121811
Complex regional pain syndromesD020918EFO_100199811
Secondary headache disordersD05127111
Show 2 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrabismusD013285HP_0000486H50.222
Alopecia areataD000506EFO_0004192L6322
ConstipationD003248HP_0002019K59.022
Treatment outcomeD01689611
DystoniaD004421HP_0001332G2411
Skin abnormalitiesD012868HP_0000951Q82.911
Muscle tonusD00912911
Physical therapy modalitiesD02674111
DysphoniaD055154R49.011
Urologic diseasesD014570N39.911
Show 22 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameACAMPROSATE
INNacamprosate
Description
Acamprosate is an organosulfonic acid that is propane-1-sulfonic acid substituted by an acetylamino group at position 3. It has a role as a neurotransmitter agent, an environmental contaminant and a xenobiotic. It is an organosulfonic acid and a member of acetamides.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)NCCCS(=O)(=O)O
Identifiers
PDB
CAS-ID77337-76-9
RxCUI82819
ChEMBL IDCHEMBL1201293
ChEBI ID51041
PubChem CID71158
DrugBankDB00659
UNII IDN4K14YGM3J (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,211 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
3,991 adverse events reported
View more details